Reaction
Incorrect Product Dosage Form Administered reporting signals
As of the last recalculation, Incorrect Product Dosage Form Administered appears in 397 FAERS reports alongside 5 co-occurring drug terms. The strongest observed disproportionality signal is GALCANEZUMAB-GNLM (PRR 63.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Galcanezumab-Gnlm | 35 | 63.8 | 63.9 |
| Guanfacine | 5 | 33.7 | 33.7 |
| Rivastigmine | 10 | 28.5 | 28.5 |
| Bosutinib | 3 | 17.6 | 17.6 |
| Tirzepatide | 44 | 15.9 | 15.9 |